Investors
Next Media's Sale Fails to Launch
Next Media's pending sale was held back by protests and other hindrances. Jimmy Lai, the Hong Kong billionaire, has offered his Taiwanese newspaper and magazine for sale but did not push through.
Cerberus Willing to Wait Three Years for Relisting
Cerberus has grandiose plans for Seibu, such as relisting after three years and expanding its shareholdings in the company.
Foxconn and Sharp Still Have No Deal Forged
A year ago, Sharp announced Foxconn would purchase shares but a year later, no agreement has been forged.
Icahn and Blackstone Open Discussion on Team Up
Icahn and Blackstone open discussion to team up on Dell buyout. Two of the most renowned equity investors in the United States may very well put a damper on the US$24.
Latest News
FCP purchases bioethanol plant for machinery to outfit the construction of another plant in the UK. UK investment company Future Capital Partners Ltd has agreed to purchase Appomattox Bio Energy LLC.
The sanitary wares giant recently sold its glassware subsidiary for an undisclosed amount. HSIL Ltd recently sold off its entire shareholdings over AGI Glasspack Ltd.
Shire pay US$160 million for SARcode Bioscience. Shire recently announced its purchase of privately owned US biotech firm SARcode Bioscience. The acquisition was worth US$160 million and central to the deal is the rights over a new drug in the late stages of development that helps cure dry eye disease.
The Taiwanese financial regulator had granted permission for Fuh Hwa Securities Investment Trust to form the yuan denominated mutual fund.
Sherpa was able to raise from investors and venture capitalist US$1.6 million for its project ventures.
CDW has filed papers of its IPO with the SEC. CDW Corp had filed documentation with US regulators reporting the raising of US$500 million in its initial public offering.
Sanofi is seeking partnership for venture capital projects for its future portfolio. France's largest drugmaker Sanofi is seeking more deals with venture capitalists such as its agreement with biotechnology company Warp Drive Bio.
Vodafone is nearing the share market valuation of Verizon, with decision time on the future of the company's venture.
Schroders pays GBP 424 million for 200 year old Cazenove Capital. Schroders, the UK based fund manager announced that it would pay GBP 424 million or US$646 million to purchase Cazenove Capital.
CSM sells off bakery supplies business to Rhone Capital for Eur850 million. CSM, the Dutch food ingredients conglomerate had announced that it sold its bakery supplies business for Eur850 million or US$1.